Major prostate cancer study gives opportunities for early treatment and longer life

The large prostate cancer study STHLM2, conducted by researchers at the Karolinska Institute, has initiated collaboration with Uppsala based bio-diagnostic company Biovica to test whether thymidine kinase is an interesting biomarker for prostate cancer.